Galectin-3 as a candidate upstream biomarker for quantifying risks of myocardial ageing
10.1002/ehf2.12495
Saved in:
Main Authors: | Keng, B.M.H., Gao, F., Ewe, S.H., Tan, R.S., Teo, L.L.Y., Xie, B.Q., Koh, W.-P., Koh, A.S. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Published: |
Wiley-Blackwell
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/212431 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
GALECTIN 3 EXPRESSION AND ITS ROLE IN HOST RESPONSE TO THE PATHOGENESIS OF HELICOBACTER PYLORI
by: VINOD VIJAYASUBHASH
Published: (2014) -
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
by: Meijers, WC, et al.
Published: (2023) -
N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing
by: Keng B.M.H., et al.
Published: (2020) -
ALTERNATIVE SPLICING AND GALECTIN-1 MODULATE L-TYPE CAV1.2 CALCIUM CHANNEL FUNCTION: IMPLICATIONS IN CARDIOVASCULAR DISEASES
by: ZHENYU HU
Published: (2018) -
Splice variant specific modulation of CaV1.2 calcium channel by galectin-1 regulates arterial constriction
by: Wang, J., et al.
Published: (2014)